1 terminated, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Adenoma, Acidophil: new trials by email Literature Review of Adenoma, Acidophil trials Research Report on Adenoma, Acidophil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 129 | 2010-03-01 | 2014-11-05 |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors temozolomide, DNA methylation analysis, microarray analysis - Brain and Central Nervous System Tumors | Phase 2 | Withdrawn | Jonsson Comprehensive Cancer Center | 2009-12-01 | 2020-07-31 |
Adenoma, Basophil (2) · Adenoma, Chromophobe (2) · Pituitary Neoplasms (2) · Prolactinoma (2) · Astrocytoma (1) · Burkitt Lymphoma (1) · Central Nervous System Neoplasms (1) · Choroid Plexus Neoplasms (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Familial ependymoma (1) · Growth Hormone-Secreting Pituitary Adenoma (1) · Leukemia, Large Granular Lymphocytic (1) · Lymphoma, Large-Cell, Anaplastic (1) · Medulloblastoma (1)
Adenoma (2) · Brain Diseases (2) · Brain Neoplasms (2) · Central Nervous System Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Hypothalamic Diseases (2) · Hypothalamic Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Nervous System Diseases (2)
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · Calcium Dobesilate (1) · DNA Methylation (1) · Dexamethasone (1) · Microarray Analysis (1) · Temozolomide (1)
Jonsson Comprehensive Cancer Center (1) · National Cancer Institute (NCI) (1)
Canada (1) · United States (1)
Anthony Heaney, MD (1) · Najat Daw (1)
U01CA097452 (1)